Physician profile
Matthew J Goldstein
NPI 1114240835
$8,676.53
in general payments reported to CMS, 2019-2025
15 companies · $863 in 2025
The $863 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,498 · 2020: $400 · 2021: $1,262 · 2022: $1,415 · 2023: $1,188 · 2024: $1,051 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,101.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $4,676.56 | 2019-2025 | Spine Truss System |
| Depuy Synthes Sales INC. | $2,811.18 | 2019-2025 | Expedium, Skyline, Symphony |
| Si-Bone, INC. | $390.64 | 2019-2024 | |
| Nuvasive, INC. | $171.22 | 2019-2023 | Alif |
| Hitachi Healthcare Americas Corp. | $140.55 | 2019 | |
| Medtronic, INC. | $120.95 | 2023-2025 | Catalyft Pl Expandable Interbody System, Micra, Atlantis Anterior Cervical Plate System |
| Shire North American Group INC | $96.47 | 2019 | |
| Orthofix Medical, INC. | $69.01 | 2019-2020 | |
| Evoke Pharma, INC. | $66.16 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $45.81 | 2022 | |
| Lemaitre Vascular, INC. | $29.25 | 2024 | Anastoclip Gc 8cm (Medium) |
| Molnlycke Health Care US, LLC | $19.16 | 2023 | Avance, Mepilex Border Post-Op Ag |
| Biomarin Pharmaceutical INC. | $16.77 | 2019 | |
| Nevro Corp. | $11.59 | 2020 | |
| Convatec INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.